User profiles for Sofia Douzgou Houge
Sofia Douzgou HougeDepartment of Medical Genetics, Haukeland University Hospital, Bergen, Norway Verified email at helse-bergen.no Cited by 3791 |
Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases
…, E Dominguez-Garrido, LD Kaat, SD Houge… - Genetics in …, 2024 - Elsevier
Purpose This study aims to assess the diagnostic utility and provide reporting recommendations
for clinical DNA methylation episignature testing based on the cohort of patients tested …
for clinical DNA methylation episignature testing based on the cohort of patients tested …
Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement
…, C Bredrup, EB Cooper, SD Houge… - Journal of medical …, 2024 - jmg.bmj.com
Rubinstein-Taybi syndrome (RTS) is an archetypical genetic syndrome that is characterised
by intellectual disability, well-defined facial features, distal limb anomalies and atypical …
by intellectual disability, well-defined facial features, distal limb anomalies and atypical …
The role of the European Society of Human Genetics in delivering genomic education
…, JT Den Dunnen, C Ding, V Dolzan, SD Houge… - Frontiers in …, 2021 - frontiersin.org
The European Society of Human Genetics (ESHG) was founded in 1967 as a professional
organisation for members working in genetics in clinical practice, research and education. …
organisation for members working in genetics in clinical practice, research and education. …
Truncating and zinc‐finger variants in GLI2 are associated with hypopituitarism
… Gunnar Houge re-evaluated previously reported GLI2 variants. Sofia Douzgou conceived
and designed the approach and submitted the manuscript. All co-authors reviewed and …
and designed the approach and submitted the manuscript. All co-authors reviewed and …
MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly
MSMO1 deficiency (OMIM# 616834) is an ultrarare autosomal recessive disorder of distal
cholesterol metabolism with only five cases reported to date. The disorder is caused by …
cholesterol metabolism with only five cases reported to date. The disorder is caused by …
[HTML][HTML] PPP2R1A-Related neurodevelopmental disorder
… Houge G 1 … changes have not been investigated, but a dominant-negative effect on protein
dephosphorylation has been shown in prior studies [Houge et al 2015, Lenaerts et al 2021]. …
dephosphorylation has been shown in prior studies [Houge et al 2015, Lenaerts et al 2021]. …
The blended phenotype of a germline RIT1 and a mosaic PIK3CA variant
We report a patient with a germline RIT1 and a mosaic PIK3CA variant. The diagnosis of the
RASopathy was confirmed by targeted sequencing following the identification of transient …
RASopathy was confirmed by targeted sequencing following the identification of transient …
[HTML][HTML] Personalised medicine for developmental disorders
…, SB Helverschou, T Skrivarhaug, SD Houge… - Tidsskrift for Den …, 2023 - tidsskriftet.no
The author has completed the ICMJE form and declares the following conflicts of interest:
she has received project support (project no. 43066) from the National Centre for Rare …
she has received project support (project no. 43066) from the National Centre for Rare …
Further clinical delineation of the MEF2C haploinsufficiency syndrome: report on new cases and literature review of severe neurodevelopmental disorders presenting …
…, B Kerr, J Clayton-Smith, S Douzgou - Journal of pediatric …, 2017 - thieme-connect.com
Mutations in the MEF2C (myocyte enhancer factor 2) gene have been established as a
cause for an intellectual disability syndrome presenting with seizures, absence of speech, …
cause for an intellectual disability syndrome presenting with seizures, absence of speech, …
Genetic disorders and genetic variants
SD Houge, GCM Black, PI Sergouniotis - Clinical Ophthalmic Genetics and …, 2022 - Elsevier
The modern era of ophthalmic genetics began in 1985 with the discovery of the retinoblastoma
gene. Remarkable progress in deciphering the genetic basis of ophthalmic disorders has …
gene. Remarkable progress in deciphering the genetic basis of ophthalmic disorders has …